Statistics

Total Visits

Views
Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)5

Select a period of time:

Number of views in the range

Views
Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)2

Views

Views
November 20230
December 20230
January 20241
February 20240
March 20240
April 20240
May 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
 

Top cities views

Views
Boardman1